1
|
Mladenov D, Yordanov S, Dimitrova A. Tulathromycin – a semi-synthetic macrolidе antibiotic. II. Usage in veterinary medicine. BULGARIAN JOURNAL OF VETERINARY MEDICINE 2023. [DOI: 10.15547/bjvm.2326] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/18/2023] Open
Abstract
This article presents the results of studies on the use of the new macrolide antibiotic tulathromycin in veterinary medicine. The information is presented according to the species of domestic animals, diseases, doses and shemes for therapy and metaphylaxis. The first section includes data for cattle and calves affected by respiratory diseases, caused by M. haemolytica, M. bovis, H. somni and P. multocida, and keratoconjunctivitis caused by M. bovis. The second one shows data for swine and pigs affected by the respiratory pathogens A. pleuropneumoniae, P. multocida, H. parasuis, B. bronhiseptica and M. hyopneumoniae. A third group presents information about small ruminants with manifested respiratory diseases caused by M. haemolytica, P. multocida, Mycoplasma spp., Pseudomonas spp. and hoof diseases from Dehelobacter nodosus. Fourth group includes the first test results of Rhodococcus equi, Streptococcus zooepidemicus, Theileria equi, Babesia bovis and Babesia bigemina, causing diseases in horses. The fifth section includes reports of treated rabbits most commonly suffering from P. multocida respiratory infections. Finally, data from new studies on the use of tulathromycin in exotic animals and cases of some tropical diseases are listed. The provided information gives proof for the high sensitivity of the tested pathogens to tulathromycin and high clinical and economical effect that is efficient in single dose of 2.5 mg/kg. Compared to other antibacterial agents there is no resistance according to data available so far. Local accumulation and prolonged persistence of the drug in lung tissues, that result in a treatment regime with a single low-volume dose (2.5 mg/kg), are associated with positive clinical outcome in domestic animals: large ruminants, pigs, small ruminants and rabbits with respiratory diseases caused by M. haemolytica, H. somni, P. multocida and M. bovis; A. pleuropneumoniae, B. bronchiseptica, P. multocida, H. parasuis and M. hyopneumoniae; S.aureus, C. pseudotuberculosis and Streptococcus spp. and P.multocida
Collapse
Affiliation(s)
| | - S. Yordanov
- National Diagnostic Research Veterinary Medical Institute „Prof. Dr. Georgi Pavlov” Sofia, Bulgaria
| | - A. Dimitrova
- National Diagnostic Research Veterinary Medical Institute „Prof. Dr. Georgi Pavlov” Sofia, Bulgaria
| |
Collapse
|
2
|
The Anti-Nociceptive Potential of Tulathromycin against Chemically and Thermally Induced Pain in Mice. Pharmaceutics 2021; 13:pharmaceutics13081247. [PMID: 34452208 PMCID: PMC8400808 DOI: 10.3390/pharmaceutics13081247] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2021] [Revised: 08/06/2021] [Accepted: 08/10/2021] [Indexed: 12/01/2022] Open
Abstract
The present study was conducted to evaluate the analgesic potential of the new triamilide macrolide antibiotic, tulathromycin, at 20 and 40 mg/kg of body weight (BW), subcutaneously against acute pain in mice. Acute pain was induced either chemically (using acetic acid-induced writhing and formalin-induced pain tests) or thermally (using hot-plate, and tail-flick tests). In the acetic acid-induced writhing test, tulathromycin induced a dose-dependent and significant decrease in the number of writhes compared with the control group. In the late phase of the formalin test, a significant decline in hind paw licking time compared with the control group was observed. In the hot-plate and tail-flick tests, tulathromycin caused a dose-dependent and significant prolongation of latency of nociceptive response to heat stimuli, compared with the control group. These findings may indicate that tulathromycin possesses significant peripheral and central analgesic potentials that may be valuable in symptomatic relief of pain, in addition to its well-established antibacterial effect.
Collapse
|
3
|
Farag MR, Elhady WM, Ahmed SYA, Taha HSA, Alagawany M. Astragalus polysaccharides alleviate tilmicosin-induced toxicity in rats by inhibiting oxidative damage and modulating the expressions of HSP70, NF-kB and Nrf2/HO-1 pathway. Res Vet Sci 2019; 124:137-148. [PMID: 30901666 DOI: 10.1016/j.rvsc.2019.03.010] [Citation(s) in RCA: 46] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2018] [Revised: 03/02/2019] [Accepted: 03/12/2019] [Indexed: 12/22/2022]
Abstract
The present study evaluated the toxic effects of Tilmicosin (TIL) on adult rats. The rats received a single subcutaneous injection of TIL at different doses (10, 25, 50, 75 and 100 mg/kg bw). TIL altered the biochemical parameters including liver and kidney function markers, glucose level and lipid profile as well as resulted in histopathological lesions in liver and adrenal glands mostly in rats exposed to 75 and 100 mg/kg bw. Then the role of Astragalus polysaccharide (APS) at 100 and 200 mg/kg bw, in modulating the toxic effects induced by high dose of TIL was evaluated. Single injection of TIL at a dose of 75 mg/kg bw was found to increase the activity of ALT, AST and ALP enzymes, induce the generation of reactive oxygen species (ROS) and decrease the total antioxidant capacity (TAC). TIL upregulated the hepatic mRNA expression of heat shock protein 70 (HSP70) and nuclear factor kappa B (NF-kB) while blocked the Nrf2/HO-1 mediated response. These changes were also associated with increasing tumer necrosis factor-alpha (TNF-α), interlukin1-beta (IL-1β) and nitric oxide levels. On the other hand, the results indicate that APS has a beneficial role particularly at high level in alleviating the stress and the hepatotoxic effects elicited by TIL injection in rats.
Collapse
Affiliation(s)
- Mayada Ragab Farag
- Forensic Medicine and Toxicology Department, Veterinary Medicine Faculty, Zagazig University, Zagazig 44519, Egypt.
| | - Wlaa M Elhady
- Forensic Medicine and Toxicology Department, Veterinary Medicine Faculty, Zagazig University, Zagazig 44519, Egypt
| | - Sarah Y A Ahmed
- Microbiology Department, Veterinary Medicine Faculty, Zagazig University, Zagazig 44519, Egypt
| | - Heba S A Taha
- Genetic Department, Faculty of Agriculture, Zagazig University, Zagazig 44519, Egypt
| | - Mahmoud Alagawany
- Poultry Department, Faculty of Agriculture, Zagazig University, Zagazig 44519, Egypt
| |
Collapse
|
4
|
Doster E, Rovira P, Noyes NR, Burgess BA, Yang X, Weinroth MD, Lakin SM, Dean CJ, Linke L, Magnuson R, Jones KI, Boucher C, Ruiz J, Belk KE, Morley PS. Investigating Effects of Tulathromycin Metaphylaxis on the Fecal Resistome and Microbiome of Commercial Feedlot Cattle Early in the Feeding Period. Front Microbiol 2018; 9:1715. [PMID: 30105011 PMCID: PMC6077226 DOI: 10.3389/fmicb.2018.01715] [Citation(s) in RCA: 40] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2018] [Accepted: 07/09/2018] [Indexed: 02/01/2023] Open
Abstract
The objective was to examine effects of treating commercial beef feedlot cattle with therapeutic doses of tulathromycin, a macrolide antimicrobial drug, on changes in the fecal resistome and microbiome using shotgun metagenomic sequencing. Two pens of cattle were used, with all cattle in one pen receiving metaphylaxis treatment (800 mg subcutaneous tulathromycin) at arrival to the feedlot, and all cattle in the other pen remaining unexposed to parenteral antibiotics throughout the study period. Fecal samples were collected from 15 selected cattle in each group just prior to treatment (Day 1), and again 11 days later (Day 11). Shotgun sequencing was performed on isolated metagenomic DNA, and reads were aligned to a resistance and a taxonomic database to identify alignments to antimicrobial resistance (AMR) gene accessions and microbiome content. Overall, we identified AMR genes accessions encompassing 9 classes of AMR drugs and encoding 24 unique AMR mechanisms. Statistical analysis was used to identify differences in the resistome and microbiome between the untreated and treated groups at both timepoints, as well as over time. Based on composition and ordination analyses, the resistome and microbiome were not significantly different between the two groups on Day 1 or on Day 11. However, both the resistome and microbiome changed significantly between these two sampling dates. These results indicate that the transition into the feedlot-and associated changes in diet, geography, conspecific exposure, and environment-may exert a greater influence over the fecal resistome and microbiome of feedlot cattle than common metaphylactic antimicrobial drug treatment.
Collapse
Affiliation(s)
- Enrique Doster
- Microbial Ecology Group, Colorado State University, Fort Collins, CO, United States.,Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, United States
| | - Pablo Rovira
- Microbial Ecology Group, Colorado State University, Fort Collins, CO, United States.,Department of Animal Sciences, Colorado State University, Fort Collins, CO, United States
| | - Noelle R Noyes
- Microbial Ecology Group, Colorado State University, Fort Collins, CO, United States.,Department of Veterinary Population Medicine, University of Minnesota, St. Paul, MI, United States
| | - Brandy A Burgess
- Department of Population Health, University of Georgia, Athens, GA, United States
| | - Xiang Yang
- Microbial Ecology Group, Colorado State University, Fort Collins, CO, United States
| | - Margaret D Weinroth
- Microbial Ecology Group, Colorado State University, Fort Collins, CO, United States.,Department of Animal Sciences, Colorado State University, Fort Collins, CO, United States
| | - Steven M Lakin
- Microbial Ecology Group, Colorado State University, Fort Collins, CO, United States.,Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, United States
| | - Christopher J Dean
- Microbial Ecology Group, Colorado State University, Fort Collins, CO, United States.,Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, United States
| | - Lyndsey Linke
- Department of Clinical Sciences, Colorado State University, Fort Collins, CO, United States
| | - Roberta Magnuson
- Department of Clinical Sciences, Colorado State University, Fort Collins, CO, United States
| | - Kenneth I Jones
- Department of Biochemistry and Molecular Genetics, University of Colorado Denver School of Medicine, Aurora, CO, United States
| | - Christina Boucher
- Department of Computer and Information Science and Engineering, University of Florida, Gainesville, FL, United States
| | - Jamie Ruiz
- Department of Computer and Information Science and Engineering, University of Florida, Gainesville, FL, United States
| | - Keith E Belk
- Microbial Ecology Group, Colorado State University, Fort Collins, CO, United States.,Department of Animal Sciences, Colorado State University, Fort Collins, CO, United States
| | - Paul S Morley
- Microbial Ecology Group, Colorado State University, Fort Collins, CO, United States.,Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, United States.,Department of Clinical Sciences, Colorado State University, Fort Collins, CO, United States
| |
Collapse
|
5
|
Lycopene Attenuates Tulathromycin and Diclofenac Sodium-Induced Cardiotoxicity in Mice. Int J Mol Sci 2018; 19:ijms19020344. [PMID: 29364179 PMCID: PMC5855566 DOI: 10.3390/ijms19020344] [Citation(s) in RCA: 45] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2017] [Revised: 01/15/2018] [Accepted: 01/17/2018] [Indexed: 01/24/2023] Open
Abstract
Recent experiments showed a potential cardiotoxic effect of the macrolide antibiotic (tulathromycin). This study was performed to investigate whether diclofenac sodium (DFS) potentiates the cardiotoxicity of tulathromycin and increases the cardioprotective effects of lycopene against DFS and tulathromycin. Seven groups (eight per group) of adult Swiss albino mice received saline (control), tulathromycin (a single subcutaneous dose of 28 mg/kg/bw on day 14), DFS (a single oral dose of 100 mg/kg/bw on day 14), tulathromycin plus DFS, or lycopene (oral, 10 mg/kg/bw daily for 15 d) combined with tulathromycin, DFS, or both. Compared to the control group, the administration of tulathromycin or DFS (individually or in combination) caused significantly elevated (p < 0.05) serum levels of Creatine kinase-myocardial B fraction (CK-MB), lactate dehydrogenase, and cardiac-specific troponin-T and tissue levels of nitric oxide and malondialdehyde that were accompanied by significantly decreased tissue reduced glutathione content and glutathione peroxidase, superoxide dismutase, and catalase antioxidant enzyme activity. Upon histopathological and immunohistochemical examination, the mean pathology scores and the percentages of caspase-3-, Bax-, and CK-positive regions were significantly higher in the tulathromycin- and/or DFS-treated groups than in control mice. For all these parameters, the pathological changes were more significant in the tulathromycin–DFS combination group than in mice treated with either drug individually. Interestingly, co-administration of lycopene with tulathromycin and/or DFS significantly ameliorated the changes described above. In conclusion, DFS could potentiate the cardiotoxic effects of tulathromycin, whereas lycopene can serve as a cardioprotective agent against DFS and tulathromycin.
Collapse
|
6
|
Czyżewska-Dors E, Kwit K, Pejsak Z, Pomorska-Mól M. Changes in circulating lymphocyte subpopulations in pigs receiving therapeutic doses of ceftiofur and tulathromycin. J Vet Res 2016. [DOI: 10.1515/jvetres-2016-0071] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Introduction: The aim of the study was to evaluate the effect of administration of therapeutic doses of ceftiofur and tulathromycin on the circulating lymphocyte subpopulations in healthy pigs. Material and Methods: The study was conducted on thirty healthy 7- to 10-week-old pigs, assigned to three groups: the TUL group, injected with tulathromycin (n = 10); the CEF group, injected with ceftiofur (n = 10); and the C group, the control with no antibiotic administration (n = 10). Blood samples were collected before, during, and after treatment with antimicrobials. Lymphocyte subpopulations circulating in the blood were determined by immunostaining and flow cytometry analyses. Results: Following administration of a therapeutic dose of tulathromycin, there were no changes in the lymphocyte subpopulations circulating in blood. In contrast, administration of ceftiofur at the recommended dose decreased the absolute number of CD3+, CD21+, CD4+CD8-, CD4-CD8+, and double positive CD4CD8 cells. Conclusion: Results from the study indicate that ceftiofur possesses the ability to modulate the immune system in healthy pigs by decreasing lymphocyte subpopulations circulating in blood.
Collapse
Affiliation(s)
- Ewelina Czyżewska-Dors
- Department of Swine Diseases, National Veterinary Research Institute, 24-100 Pulawy, Poland
| | - Krzysztof Kwit
- Department of Swine Diseases, National Veterinary Research Institute, 24-100 Pulawy, Poland
| | - Zygmunt Pejsak
- Department of Swine Diseases, National Veterinary Research Institute, 24-100 Pulawy, Poland
| | | |
Collapse
|
7
|
Tissue residues, hematological and biochemical effects of tilmicosin in broiler chicken. Vet Med Int 2014; 2014:502872. [PMID: 24808972 PMCID: PMC3998004 DOI: 10.1155/2014/502872] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2013] [Accepted: 02/20/2014] [Indexed: 11/17/2022] Open
Abstract
The aim of this study was to determine the blood and tissue concentrations profile and effect of tilmicosin on some hematological and biochemical parameters in broiler chicken. Fifty clinically healthy Hubbard chickens were orally administered 25 mg/kg BW of tilmicosin once daily for 5 consecutive days. Tissue residues of tilmicosin in slaughtered healthy chicken could not be detected by microbiological assay in all tested tissues except in lung (at 96 hours) and liver and kidneys (at 72 hours) after last administration. Tilmicosin caused temporary decrease in the RBCs and WBCs counts and has no effect on hemoglobin (Hb) and packed cell volume concentration (PCV). Also, the effect of tilmicosin on some biochemical parameters was as follows: the concentrations of creatinine, uric acid, electrolytes (sodium, potassium, and calcium), glucose, AST, ALT, ALP, and HDL-cholesterol in the serum of treated chicken did not change in response to the repeated oral administration of tilmicosin. There were only a temporary significant decrease in total protein and albumin concentrations and a significant increase in cholesterol and triglycerides concentrations. Chicken must not be slaughtered before 4 days from the stopping of tilmicosin administration. Tilmicosin makes temporary changes on hematological and biochemical parameters in broiler chicken.
Collapse
|
8
|
Cardiac safety of diclofenac at a single dose in ram. ScientificWorldJournal 2013; 2013:808731. [PMID: 24228015 PMCID: PMC3817638 DOI: 10.1155/2013/808731] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2013] [Accepted: 09/05/2013] [Indexed: 11/23/2022] Open
Abstract
Nonsteroidal anti-inflammatory drugs are frequently prescribed drug group in human and veterinary medicine. However, diclofenac, a traditional nonsteroidal anti-inflammatory drug, related to cardiotoxicity is reported, and blood cardiac damage markers may increase within the first hours after damage. The aim of the current research was to determine the effect of diclofenac on the blood cardiac damage markers. Single dose of diclofenac (2.5 mg/kg, IM) was injected to 6 rams. Blood samples were collected in before (0 hour, control) and 6 hours after injection. Specific (troponin I, and creatine kinase-MB) and nonspecific (lactate dehydrogenase, aspartate aminotransferase) blood cardiac damage marker concentrations, routine biochemical (hepatic damage, renal damage, lipid metabolism, glucose, and phosphorus) parameters, and hemogram values were measured. Diclofenac increased (P < 0.05) specific (troponin I) and nonspecific cardiac (lactate dehydrogenase, aspartate aminotransferase), hepatic (aspartate aminotransferase, alkaline phosphatase, and alanine aminotransferase), and muscular (creatine kinase) damage markers and high density lipoprotein level, while it decreased (P < 0.05) low density lipoprotein level. Moreover, diclofenac decreased (P < 0.05) white blood cell counts and increased (P < 0.05) red blood cell counts. In conclusion, it may be stated that diclofenac shows slight cardiotoxicity, whereas it may show potent hepatic and muscular damage effects at an intramuscularly single dose in sheep. Thereby, repeated injections of diclofenac may be more harmful in sheep.
Collapse
|